{"subsection_name": null, "pub_date": "2011-10-19T15:17:24Z", "byline": {"original": "By DEALBOOK", "person": [{"organization": "", "role": "reported", "rank": 1}]}, "abstract": "As the number of corporate spinoffs mounts, Lazard so far leads a Thomson Reuters league table for advising on them.", "word_count": 224, "print_page": null, "news_desk": null, "snippet": "As the number of corporate spinoffs mounts, Lazard so far leads a Thomson Reuters league table for advising on them.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "organizations", "value": "Goldman Sachs Group Inc", "rank": "4"}, {"name": "organizations", "value": "Credit Suisse Group AG", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "organizations", "value": "Lazard Llc", "rank": "5"}, {"name": "type_of_material", "value": "News", "rank": "1"}, {"name": "organizations", "value": "Morgan Stanley", "rank": "6"}, {"name": "unknown", "value": "Credit Suisse Group AG|CS|NYSE", "rank": "7"}, {"name": "unknown", "value": "Goldman Sachs Group Inc|GS|NYSE", "rank": "8"}, {"name": "unknown", "value": "Morgan Stanley|MS|NYSE", "rank": "9"}], "type_of_material": "Blog", "lead_paragraph": "Morgan Stanley snagged a nice piece of business in advising Abbott Laboratories on the planned spinoff of its research drug division.", "web_url": "http://dealbook.nytimes.com/2011/10/19/the-breakup-advisers/", "section_name": "Business Day", "headline": {"main": "The Breakup Advisers", "kicker": "DealBook"}, "slideshow_credits": null, "_id": "4fd3a16a8eb7c8105d8e810b", "document_type": "blogpost"}